Acinetobacter corneal graft ulcer and endophthalmitis: Report of two cases

Canadian Journal of Ophthalmology

Volumn 40, Issue 1, 2005, Pages 79-82

  Levy, Jaime ^a   Oshry, Tzafrir ^a   Rabinowitz, Ronen ^a   Lifshitz, Tova ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acinetobacter; Endophthalmitis; Intensive care unit; Penetrating keratoplasty; Ulcer

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; CHLORAMPHENICOL; COLISTIN; DEXAMETHASONE; FLUCONAZOLE; GENTAMICIN; VALACICLOVIR; VANCOMYCIN;

ACINETOBACTER; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CORNEA TRANSPLANTATION; CORNEA ULCER; DISEASE COURSE; ENDOPHTHALMITIS; FEMALE; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; MALE; PENETRATING KERATOPLASTY; VISUAL ACUITY;

EID: 16344363845     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(05)80123-1     Document Type: Article

References (16)

1. Marcovich A, Levartovsky S. Acinetobacter exposure keratitis. Br J Ophthalmol 1994;78(6):489-90.
2. Zabel RW, Winegarden T, Holland EJ, Doughman DJ. Acinetobacter corneal ulcer after penetrating keratoplasty. Am J Ophthalmol 1989;107(6):677-8.
3. Crawford PM Jr, Conway MD, Peyman GA. Trauma-induced Acinetobacter lwoffi endophthalmitis with multi-organism recurrence: strategies with intravitreal treatment. Eye 1997;11:863-4.
4. Melki TS, Sramek SJ. Trauma-induced Acinetobacter Iwoffi endophthalmitis. Am J Ophthalmol 1992;113(5): 598-9.
5. Gopal L, Ramaswamy AA, Madhavan H, Saswade M, Battu RR. Postoperative endophthalmitis caused by sequestered Acinetobacter calcoaceticus. Am J Ophthalmol 2000;129(3):388-90.
6. Prashanth K, Ranga PM, Rao VA, Kanungo R. Corneal perforation due to Acinetobacter junii: a case report. Diagn Microbiol Infect Dis 2000;37(3):215-7.
7. Khater TT, Jones DB, Wilhelmus KR. Infectious crystalline keratopathy caused by gram-negative bacteria. Am J Ophthalmol 1997;124(1):19-23.
8. Corrigan KM, Harmis NY, Willcox MDP. Association of Acinetobacter species with contact lens-induced adverse responses. Cornea 2001;20(5):463-6.
9. Allen DM, Hartman BJ. Acinetobacter species. In: Mandell GL, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. Vol 2. Philadelphia: Churchill Livingstone; 2000. p. 2339-42.
10. Lopez-Hernandez S, Alarcon T, Lopez-Brea M. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates.] Rev Esp Quimioter 2000;13:394-400.
11. Hejnar P, Kolar M, Hajek V. Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc. Acta Univ Palacki Olomuc Fac Med 1999;142:73-7.
12. Ruiz J, Nunez ML, Ferez J, Simarro E, Martinez-Campos L, Gomez J. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis 1999;18:191-5.
13. Chambers HF. Antimicrobial agents. In: Hardman JG, Limbird LE, Goodman Gilman A, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1261-2.
14. Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001;7:434-40.
15. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001;39:183-90.
16. Smith TM, Popplewell J, Nakamura T, Trousdale MD. Efficacy and safety of gentamicin and streptomycin in Optisol-GS, a preservation medium for donor corneas. Cornea 1995;14(1):49-55.